Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2014

Feb 20, 2014

34807_dirs_2014-02-20_9d8c535b-9f2f-47b1-aa10-d2ad3e851651.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIOD)
CIK: 0001043961
Period of Report: 2014-02-18

Reporting Person: Koppler Doit II (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-18 Option to Purchase Common Stock $5.54 A 3000 Acquired 2024-02-17 Common Stock (3000) Direct